Walgreens Consumer Drops Appeal in Infant Pain Relief Price Suit

May 18, 2021, 3:14 PM

A Walgreen Co. consumer has voluntarily dismissed his appeal seeking to reinstate a proposed class suit in California alleging the pharmacy chain tricks parents into believing only an expensive “infants” acetaminophen product is safe for very young children, court filings show.

Cameron Eidmann alleged Walgreens misled customers into believing its private-label product, which costs four times more than the “children’s version,” is specially formulated for infants when both have the same concentration of active ingredient.

The suit was dismissed in February. No reasonable consumer would understand the infants’ product to be so designed, Judge Edward J. Davila of the U.S. ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.